Search SEC
Fundamental Analysis
2 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STLNStarling Oncology, Inc. | 50.9 | 96.2 | 97.7 | 75 | +42.14% | -51.74% | n/a | +12.98% | +33.64% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
| STLNWStarling Oncology, Inc. | 50.9 | 96.2 | 97.7 | 75 | +42.14% | -51.74% | n/a | +12.98% | +33.64% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction2 warnings |
1-2 of 2